DK0533898T3 - Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande - Google Patents

Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande

Info

Publication number
DK0533898T3
DK0533898T3 DK92909629T DK92909629T DK0533898T3 DK 0533898 T3 DK0533898 T3 DK 0533898T3 DK 92909629 T DK92909629 T DK 92909629T DK 92909629 T DK92909629 T DK 92909629T DK 0533898 T3 DK0533898 T3 DK 0533898T3
Authority
DK
Denmark
Prior art keywords
treatment
methods
conditions
compositions
hypoglycemia
Prior art date
Application number
DK92909629T
Other languages
Danish (da)
English (en)
Inventor
Kevin Beaumont
Andrew A Young
Original Assignee
Amylin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/670,231 external-priority patent/US5264372A/en
Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc
Application granted granted Critical
Publication of DK0533898T3 publication Critical patent/DK0533898T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008—Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92909629T 1991-03-15 1992-03-13 Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande DK0533898T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/670,231 US5264372A (en) 1991-03-15 1991-03-15 Receptor-based screening methods for amylin agonists and antagonists
US70499591A 1991-05-24 1991-05-24
US07/774,411 US5321008A (en) 1991-01-10 1991-10-10 Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
PCT/US1992/002191 WO1992016222A1 (fr) 1991-03-15 1992-03-13 Procedes et compositions de traitement du diabete sucre, de l'hypoglycemie et d'autres etats pathologiques

Publications (1)

Publication Number Publication Date
DK0533898T3 true DK0533898T3 (da) 1999-05-31

Family

ID=27418205

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909629T DK0533898T3 (da) 1991-03-15 1992-03-13 Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande

Country Status (11)

Country Link
US (2) US5321008A (fr)
EP (1) EP0533898B1 (fr)
JP (1) JPH05507943A (fr)
AT (1) ATE170401T1 (fr)
AU (1) AU648895B2 (fr)
CA (1) CA2082928C (fr)
DE (1) DE69226835T2 (fr)
DK (1) DK0533898T3 (fr)
ES (1) ES2122995T3 (fr)
MX (1) MX9201110A (fr)
WO (1) WO1992016222A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234906A (en) * 1991-01-10 1993-08-10 Amylin Pharmaceuticals, Inc. Hyperglycemic compositions
JP2818296B2 (ja) * 1991-01-10 1998-10-30 アミリン・ファーマシューティカルズ・インコーポレイテッド アミリン活性検定
HU222249B1 (hu) * 1991-03-08 2003-05-28 Amylin Pharmaceuticals Inc. Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US5814600A (en) * 1991-05-24 1998-09-29 Amylin Pharmaceuticals Inc. Method and composition for treatment of insulin requiring mammals
US6143718A (en) 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
US7312196B2 (en) * 1997-01-08 2007-12-25 Amylin Pharmaceuticals, Inc. Formulations for amylin agonist peptides
US6410511B2 (en) 1997-01-08 2002-06-25 Amylin Pharmaceuticals, Inc. Formulations for amylin agonist peptides
US7101853B2 (en) * 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en) * 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
US5929055A (en) * 1997-06-23 1999-07-27 The Research Foundation Of State University Of New York Therapeutic method for management of diabetes mellitus
ES2316161T3 (es) * 1998-01-09 2009-04-01 Amylin Pharmaceuticals, Inc. Formulaciones para peptidos agonistas de amilina con insulina.
EP1053001B1 (fr) 1998-02-13 2010-12-15 Amylin Pharmaceuticals, Inc. Nouveaux composes a activite mixte par rapport a l'amyline
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
BR0114909A (pt) * 2000-10-26 2004-02-03 Alza Corp Dispositivos de distribuição de drogas transdérmicas possuindo microprotuberâncias revestidas
JP2006514990A (ja) * 2002-12-27 2006-05-18 ディオベックス， インコーポレイテッド インスリン誘発性低血糖の予防および制御のための組成物および方法
US7655618B2 (en) * 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7812120B2 (en) 2003-03-21 2010-10-12 Par Pharmaceutical, Inc. Nasal calcitonin formulations containing chlorobutanol
EP1778266A4 (fr) * 2004-06-29 2009-09-09 Diobex Inc Compositions et methodes pour la prevention et la regulation de l'hypoglycemie induite par l'insuline
WO2009156473A1 (fr) * 2008-06-25 2009-12-30 Novo Nordisk A/S Peptides hybrides dérivés d’amyline et de calcitonine de saumon
MX2011009559A (es) * 2009-03-12 2012-01-12 Nordic Bioscience As Tratamiento de la diabetes y el sindrome metabolico.
JP7133229B2 (ja) 2017-02-03 2022-09-08 ヴァンダービルト ユニバーシティー 糖尿病を治療するためのシステム、組成物および方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
GB8720115D0 (en) * 1987-08-26 1987-09-30 Cooper G J S Treatment of diabetes mellitus
WO1989006135A1 (fr) * 1988-01-11 1989-07-13 Amylin Corporation Traitement du diabete sucre du type 2
DK0408294T3 (da) * 1989-07-10 1996-01-15 Amylin Pharmaceuticals Inc Anvendelse af en amylinantagonist til fremstilling af et lægemiddel til behandling af fedme og essentiel hypertension og beslægtede lidelser

Also Published As

Publication number Publication date
US5321008A (en) 1994-06-14
DE69226835T2 (de) 1999-01-14
ATE170401T1 (de) 1998-09-15
AU648895B2 (en) 1994-05-05
EP0533898B1 (fr) 1998-09-02
EP0533898A4 (en) 1993-10-13
ES2122995T3 (es) 1999-01-01
CA2082928A1 (fr) 1992-09-16
AU1687392A (en) 1992-10-21
MX9201110A (es) 1993-07-01
DE69226835D1 (de) 1998-10-08
JPH05507943A (ja) 1993-11-11
CA2082928C (fr) 2000-09-05
WO1992016222A1 (fr) 1992-10-01
EP0533898A1 (fr) 1993-03-31
US5508260A (en) 1996-04-16

Similar Documents

Publication Publication Date Title
DK0533898T3 (da) Fremgangsmåder og sammensætninger til behandling af diabetes mellitus, hypoglykæmi og andre tilstande
DE68929217T2 (de) Insulinotropes hormon
DK0682529T3 (da) Antistof til behandling af insulinkrævende diabetes
DK0762890T3 (da) Behandling af diabetes
NO940436L (no) Forlenget avgivelse av peptider
DK569788A (da) Indretning til sammenkobling af injektionssproejte og beholder
DE69327309D1 (de) Verwendung eines peptids
DE68911056T2 (de) Kupplungsstück für Kolben von Spritzen für eine subkutane Injektion.
EA200000748A1 (ru) Способ введения мономерных аналогов инсулина
NL7803289A (nl) Peptiden met biologische werking op de inhibitie van groeihormoon-, insuline- en glucagonsecretie.
DE69107584T2 (de) Analoges, elektronisches Zeitgerät mit elektrooptischer Anzeige.
TR200000134T2 (tr) Tiazolidinedion, ensülin salgılatıcısı ve biguanid ile diabetin (şeker hastalığının) tedavisi.
EP0672060A4 (fr) Antigene associe au diabete sucre de type i.
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
DK0586589T3 (da) Amylin- eller amylinanalogpræparat, som eventuelt indeholder insulin, til behandling af anoreksi og beslægtede tilstande
ES2106169T3 (es) Anticuerpos monoclonales especificos del cd4 y que no provocan agotamiento, destinados para el tratamiento de diabetes mellitus dependiente de insulina (idmm).
KR810002505Y1 (ko) 자동주사기에 있어서 반복주입 제어장치
HUP0002668A2 (hu) Diabetes kezelésére dioxo-tiazolidinnel és metforminnal
IT1252879B (it) Siringa anticontagio in caso di riuso da parte di una seconda persona,autopulente con serbatoio aggiuntivo regolato da valvole e tale che ilsangue aspirato rimanga contenuto nel serbatoio in modo da non poter essere reiniettato e da non poter entrare in contatto con il liquido da iniettare
ES2029596A6 (es) Jeringuilla interdigital monomanual.
ES276023Y (es) Un dispoitivo para contener frascos de insulina y jeringas de inyeccion utilizables por diabeticos.
IT9033301U1 (it) Siringa anticontagio con ago retrattile sia manualmente che meccanicam ente monouso-parifunzionali da utilizzare per iniezioni di insulina, p er pratiche ospedaliere e domestiche e per prelievi.
ES1025068Y (es) Jeringuilla para poner inyecciones valedera para una sola vez, que permite al usuario inyectarse solo una vez.
DK647788D0 (da) Anvendelse af aldosereduktaseinhibitorer til foroegelse af insulineffektivitet i diabtes mellitus.